The FDA’s Center for Biologics Evaluation and Research (CBER), Office of Therapeutic Products (OTP) is hosting a webinar on Thursday, January 30th, 2025 from 1:00 – 2:00 p.m. ET. During this webinar, leaders from across OTP will provide information about how the office is helping to advance cell and gene therapy product development through innovati
Prostate cancer, advanced prostate cancer, novel targets for mHSPC, Metastatic Hormone Sensitive Prostate Cancer (mHSPC), TITAN study, ENZAMET trial, ARCHES trial, CHAARTED trial, Prognostication in…
NIH policy asks companies seeking licenses to sell medical products invented with government research to submit plans for ensuring greater access to patients.
Daniel Ek is cranking up the volume at Spotify Technology . Two years ago, the U.S.-listed music streamer faced heat from activist investor ValueAct Capital…
From innovating ways to preserve glacial ice to predicting climate-driven migration shifts to building resilient cities, researchers are exploring scalable solutions to safeguard a planet…
Welcome to Scribe, your new assistant for clinical note-taking! This HIPAA compliant AI-powered tool listens to your patient visits and creates an EHR-ready summary. Say…
For the second time in less than a year, the FTC has released a highly critical report of pharmacy benefit managers, or PBMs.
FDA Proposes Rule that Would Help Consumers Quickly and Easily Identify how Foods Can Be Part of a Healthy Diet by Requiring a Nutrition Info…
prostate cancer, metastatic castration resistant prostate cancer (mCRPC), Metastatic Castrate-Resistant Prostate Cancer Disease Space, EPI-7386, EPI-7386 plus Enzalutamide, Enzalutamide, RNAseq, CYPIDES trial, Oral bavdegalutamide (ARV-110),…
Nature Communications – Using the National Ecological Observatory Network (NEON) as an example, this perspective discusses actions that recognize the sovereign rights of Indigenous Peoples…
